Insider · CIK 0001944868
Bryan J McMichael
cfoofficer
Files at CHRS (Coherus Oncology, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | CHRS Coherus Oncology, Inc. | AGrant or award Common Stock | +112,500 | $0.00 | $0 | 133,736 | Jan 26, 2026 |
| Jan 22, 2026 | CHRS Coherus Oncology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +225,000 | $0.00 | $0 | 225,000 | Jan 26, 2026 |
| Jan 20, 2026 | CHRS Coherus Oncology, Inc. | FTax withholding Common Stock | -1,715 | $1.55 | $2,658 | 21,236 | Jan 22, 2026 |
| May 7, 2025 | CHRS Coherus Oncology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +200,000 | $0.00 | $0 | 200,000 | May 9, 2025 |
| Jan 20, 2025 | CHRS Coherus Oncology, Inc. | FTax withholding Common Stock | -1,711 | $1.39 | $2,378 | 22,951 | Jan 22, 2025 |
| Jan 7, 2025 | CHRS Coherus Oncology, Inc. | FTax withholding Common Stock | -1,711 | $1.57 | $2,686 | 24,662 | Jan 10, 2025 |
| Jan 3, 2025 | CHRS Coherus Oncology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +160,000 | $0.00 | $0 | 160,000 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.